Compile Data Set for Download or QSAR
maximum 50k data
Found 5 Enz. Inhib. hit(s) with Target = 'Substance-K receptor' and Ligand = 'BDBM50112243'
TargetSubstance-K receptor(Homo sapiens (Human))
Euroscreen

US Patent
LigandPNGBDBM50112243(CHEMBL3608682 | US10030025, Compound 28 | US108367...)
Affinity DataKi: >3.00E+4nM ΔG°: >-25.8kJ/molepH: 7.4 T: 2°CAssay Description:The affinity of compounds of the invention for the NK-2 receptor was evaluated in CHO recombinant cells which express the human NK-2 receptor. Membra...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Euroscreen

US Patent
LigandPNGBDBM50112243(CHEMBL3608682 | US10030025, Compound 28 | US108367...)
Affinity DataKi: >3.00E+4nM ΔG°: >-25.8kJ/molepH: 7.4 T: 2°CAssay Description:The affinity of compounds of the invention for the NK-2 receptor was evaluated in CHO recombinant cells which express the human NK-2 receptor. Membra...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Euroscreen

US Patent
LigandPNGBDBM50112243(CHEMBL3608682 | US10030025, Compound 28 | US108367...)
Affinity DataKi: >3.00E+4nMAssay Description:The affinity of compounds of the invention for the NK-2 receptor was evaluated in CHO recombinant cells which express the human NK-2 receptor. Membra...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Euroscreen

US Patent
LigandPNGBDBM50112243(CHEMBL3608682 | US10030025, Compound 28 | US108367...)
Affinity DataKi: >3.00E+4nMAssay Description:The affinity of compounds of the invention for the NK-2 receptor was evaluated in CHO recombinant cells which express the human NK-2 receptor. Membra...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Euroscreen

US Patent
LigandPNGBDBM50112243(CHEMBL3608682 | US10030025, Compound 28 | US108367...)
Affinity DataKi: >3.00E+4nMAssay Description:Human NK-2 The affinity of compounds of the invention for the NK-2 receptor was evaluated in CHO recombinant cells which express the human NK-2 recep...More data for this Ligand-Target Pair
In DepthDetails US Patent